Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Cortisone Injection and Splinting for Trigger Finger
NCT03156829Phase 4Unknown
- Start
- Nov 2017
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of betamethasone in trigger finger (3 arms). Primary endpoint: Resolution of symptoms at 1 year. Status: unknown.
02
Drugs
betamethasone
03
Conditions
trigger finger
Beyond the preview
Go deeper on NCT03156829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03156829.